Reviva Pharmaceuticals' brilaroxazine shows promise for schizophrenia, but regulatory and financial risks persist. Read why ...

A research team led by Dr Brian Chung Hon-yin (third left) has revealed that individuals who experienced childhood maltreatment face markedly elevated ...

Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a ...

New research from the Institute of Psychiatry, Psychology & Neuroscience, supported by the Population Mental Health ...

People with schizophrenia often take strong antipsychotics that control symptoms but frequently cause rapid weight gain, high blood sugar, and a ...

Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...

Directed by Eric Lin, this downbeat, superbly acted drama presents a family in crisis and a worried mother who contemplates ...

By Dennis Thompson HealthDay ReporterMONDAY, Dec. 15, 2025 (HealthDay News) — Most people receiving shock therapy for mental ...

The marijuana industry has sold us a bill of goods, and we’ve given ourselves over to a mass mania, disregarding scientific ...

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a broad patient population 2 Olanzapine LAI is designed ...

Catherine Hoggle, accused of killing her two children in 2014, has been deemed mentally competent to stand trial by a ...